Stocks and Investing Stocks and Investing
Mon, October 26, 2020

Ed Arce Maintained (AKBA) at Strong Buy with Decreased Target to $9 on, Oct 26th, 2020


Published on 2024-10-27 14:29:55 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Decreased Target from $10 to $9 on, Oct 26th, 2020.

Ed has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Robert Hazlett of "BTIG" Maintained at Strong Buy with Decreased Target to $6 on, Friday, September 4th, 2020
Contributing Sources